Sudden onset of large pericardial effusion in a 27-year-old man with AIDS.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to T Tan.
Explore the source record for details and available documents.
In the present study data on blood cell count, serum biochemistry, electrolyte, enzyme and vital organs of 93 patients with bone tumor or metastasis were investigated before and after treatment with 153Sm-EDTMP. The results showed that, 7 days and 30 days after the administration of 153Sm-EDTMP (< 29.6 MBq) (0.8 mCi/kg), the levels of hemoglobin, WBC lymphocyte count, and the liver and kidney function of all patients were not significantly different from the baseline data before treatment (P > 0.05). Although at 7 days, there was a declination of the granulocyte count, it returned to normal at 30 days (P > 0.05). The platelet count was significantly decreased (0.05 > P > 0.01). at 30 days after the administration of 153Sm-EDTMP. Thirteen patients received 74-185 MBq (2-5mCi/kg) and their myelo biopsies at 3 and 18 months showed no sign of acute or chronic toxicosis.
In this paper, an experimental research is reported on the effect of water extract of Cladonia alpestris and S-(-) usnic acid on Trichomonas vaginalis in vitro. The results showed that both the water extract of Cladonia alpestris and S-(-)usnic acid exhibited a strong effect against Trichomonas vaginalis in vitro. As the time of action of the agents was prolonged, the mortality of Trichomonas vaginalis increased. For S-(-) usnic acid, 0.4 mg/ml was the lowest effective concentration against Trichomonas vaginalis in vitro. No remarkable differences were found in the effect of the S-(-)usnic acid and metronidazole at concentrations of 0.4 mg/ml and 0.6 mg/ml.
Based on the receptor competitive binding assays in the mice and rat body, it has been proved that both diazepam and alpha-sec-butyl-p-hydroxybenzyl alcohol (G-018) can inhibit 125I-G-018 binding with brain benzodiazepine receptor. Inhibiting effects were obvious in the cortex, cerebellum, hippocampus and midbrain. But in the medullao blongata and hypothalamus no inhibiting effect was observed. Experimental results have demonstrated that the inhibiting effect is consistent with distribution of benzodiazepine receptor in the brain. Also, experimental results have shown no difference between in vitro and in vivo. The G-018 binding with benzodiazepine receptor has been clarified under physiologic conditions.
The biodistribution and metabolism of 3H-gastrodigenin and 3H-gastrodin after intravenous injection were studied by the detection of their radioactivity in mice tissue; the radioactive elements of mice tissue extracts after intravenous injection of 3H-gastrodin were analyzed with thin-layer chromatography (TLC). The results demonstrated that gastrodin could penetrate through the blood-brain barrier into the brain, and it was rapidly decomposed into the gastrodigenin in brain, liver and blood. Then gastrodigenin preserved in brain and mediated its pharmacological inhibitive effects on the central nervous system. Most of the gastrodigenin and gastrodin were excreted by the kidney. The findings also suggested that gastrodin might exist in the enterohepatic circulation.
This paper reports results of an assay of the binding of 99mTc-galactosylneoglycoalbumin (NGA) and plasma membranes of the rat liver in vitro. The data showed that 99mTc-NGA could be bound to the membrane receptor with high affinity. Specificity and saturability, and that the amount of membrane-bound 99mTc-NGA varied linearly with the amount of membrane within each reaction tube. The biphasic curve of scatchard plot revealed that 99mTc-NGA was bound to two sites of the receptor with different affinity and concentration (K1 8.4089 x 10(9) L/mol, R1 1.7350 x 10(-12) mol/mg); K2 2.0827 x 10(8) L/mol, R2 6.9530 x 10(-12) mol/mg). Therefore, the authors consider that 99mTc-NGA is a promising hepatic receptor agent for imaging.
A total of 49 patients with paucibacillary leprosy (PB) who completed multidrug therapy (MDT) between 1985 and 1990 were analysed retrospectively for efficacy and complications; 20 (40.8%) patients had borderline-tuberculoid (BT), 13 (26.5%) had tuberculoid (TT), 1 (2.1%) had indeterminate (I) and 15 (30.0%) had pure neural (N) leprosy; 26 patients (76.5% of 34 non-neural leprosy) were skin biopsied for histological cure before MDT was stopped. Of these 26 patients, 19 had histological clearance at 6 months while the remaining 7 cleared beyond 1 year (18-36 months). The remaining 8 non-neural patients who refused rebiopsy had MDT for 6-8 months and the MDT was stopped when there was clinical clearance. Of the 15 neural (N) leprosy patients, 11 were given MDT for 6 months while the rest had 12-18 months of treatment; 1 patient with neural leprosy, who was treated for 6 months, relapsed with BT leprosy 18 months post-treatment. There were few complications among the 49 patients-4 (8.2%) patients developed reaction to dapsone, 1 (2.0%) had the dapsone syndrome, 2 (4.1%) had haemolytic anaemia and 1 (2.0%) had dapsone hepatitis; 7 (14.3%) patients had type I reaction.
The preparation of one-step kit for the 99mTc labelled galactosyl-neo-glycoalbumin (NGA) using SnCl2 reduced method was reported in this paper. We developed a method of quality control and established the optimum scheme of technetium labelling on the basis of exploring the effects of varied labelled conditions on radiochemical purity. Our data indicates : (a) the kit is sterile, pyrogen-free and no toxic effects; (b) the operation is simple and fast; (c) its period of validity lasts no less than 3 months; (d) the radiochemical purity > 95%; (e) the stability of 99mTc-NGA in vitro > 4 hours; (f) the results of animal imaging and clinical probation are satisfactory.
Two normal subjects and three patients with hepatic disease were intravenously injected each with a single dose of 99mTc-NGA (galactosyl-neoglycoalbumin), a liver receptor imaging agent. The results showed that pharmacokinetics of 99mTc-NGA accorded with the two compartment open model. In the normal subjects, T1/2 alpha and T1/2 beta averaged 1.65 and 19.39 min respectively, indicating a rapid distribution process and a slow elimination process. There were significant differences in pharmacokinetics of 99mTc-NGA between the normal subjects and the patients with hepatic disease, and therefore the relevant parameters are of importance for the evaluation of hepatic function.
Nine patients with inoperable hepatoma were treated by using hepatic arterial embolization 131I and chemotherapeutic agent gelatin microsphere (131I-CA-GM). The emission CT after operation detected that the microspheres were concentrated on tumor area. The ratio between the radioactivity in tumor and that in liver was 4.1:1. A case died of ictopic embolization; the others survived 3, 4, 5, 19, 24, 7, 8, and 12 months respectively. Three of them were still alive. 131I-CA-GM has triple anticarcinogenic actions, including the arterial occlusion, targeting chemotherapy and internal radiation. The microspheres can selectively accumulate in the tumor artery and can be easily traced by gamma-camera or emission CT. 131I-CA-GM is a hopeful embolic agent for the treatment of liver cancer, but some problems about ectopic arterial embolization should be further studied.
It has been widely reported that shoe inserts are an effective interventional modality either for the relief of discomfort to the feet associated with a variety of orthopedic disorders or conditions or simply for comfort. Results from many types of experimental tests have been used to obtain the shock absorption capacity of shoe insert materials. The authors contend in this study that, while shock absorption is a highly desirable property, it is by no means the only that should be used to characterize these materials. Thus, a new index of performance of these materials is proposed. This index is computed from data, obtained in a simple experimental test, on both the shock absorption and energy return performances of the insert material.
The tritiated alpha-isobutylhydroxybenzyl alcohol (3H-G018) was found to be able to bind benzodiazepine (BZ) receptor on the rat brain membrane. The 125I labeled G-018 also had the similar binding activity with this receptor. In the present investigation, we observed that gastrodigenin and its derivatives inhibited the 125I-G018 binding of BZ receptor competitively, but no inhibition was observed with gastrodin. The results suggested that Gastrodigenin was bound to BZ receptor, and otherwise, gastrodin would have no direct interaction with BZ receptor. Probably, it might metabolize into gastrodigenin in vivo, and then got through the blood brain barrier and bound to BZ receptor, which mediated its pharmacological effects on the central nervous system.
We designed a new gelatin microsphere (GM, 65 micron in diameter), which could combine with mitomycin C and 131I. The test in vitro showed that the GM had excellent drug release effect. Hepatic arterial embolization was carried out in 6 dogs with 131I-MMC-GM. The dogs survived from 4 to 28 days before being killed. Scintigraphy indicated that high radioactivity was concentrated in the liver, but was very low in the blood and thyroid. Pathologic study found that the GM was trapped in hepatic arterioles. The GM was eliminated by foreign body giant cells and the lumen of arterioles was occupied by granulations 14-28 days after operation. 131I-MMC-GM is a multiple anticancer agent which can exert triple action of targeting chemotherapy, internal radiotherapy and arterial embolization.
This is a report on the synthesis of hexamethyl-propylene-amine oxime (HM-PAO), a new agent for regional cerebral blood flow (gamma CBF) imaging, the separation of its diastereoisomers (dl- and meso-HM-PAO), and a comparative study of three forms of Tc- 99m labelled HM-PAO (dl-, meso- and mixture-) in chromatography, mice biodistribution and rabbit imaging. The results showed that the Rf value of Tc-99m-dl-HM-PAO (0.8-1.0) on silica G thin layer chromatography with MEK as solvent was different from that of Tc-99m-meso-HM-PAO (0.6-0.8), and that the retention of dl- isomer in the brain was higher and more static than those of meso-and mixture HM-PAO but identical with Ceretec, a dl-HM-PAO kit manufactured by Amersham Inc., England. The primary clinical applications for gamma CBF SPECT imaging demonstrated a satisfactory result.
Galactosyl-neoglycoalbumin (NGA) can bind with the asialoglycoproteins receptor specifically on the surface of mammal's liver. We prepared NGA in different carbohydrate density and made some animal and clinical tests with technetium-99m labeled NGA. The maximum absorption of 99mTc-NGA-21 was 82.6% in liver. We also got the satisfactory radiographs of liver. NGA was synthesized by the covalent coupling of a carbohydrate bifunctional reagent, 2-imino-2-methoxyethyl-1-thio-galactose (4), to human serum albumin. The cyanomethyl-1-thio-glycoside of beta-D-galactose (3) was prepared from the pseudothiourea derivative (2) which was synthesized by acetylation, bromination and substitution of galactose (3) could be converted to (4) by treatment with sodium methoxide.
The effect of sperm penetration capacity after selection procedures using Percoll (Pharmacia AB, Uppsala, Sweden) and Nycodenz (Nycomed Diagnostics, Oslo, Norway) gradient centrifugation was compared with double-washed and swim-up in 47 subfertile men. The results of sperm motility, velocity, and amplitude lateral head displacement showed no significant improvement with the centrifugation procedures. The sperm penetration assay results obtained with double-washed and swim-up technique were poor (2.7% +/- 1.7%), however, a significant enhancement was obtained by Percoll (16.3% +/- 3.7%) and Nycodenz (15.8% +/- 3.3%) processing. Nycodenz centrifugation allowed sperm penetration of zona-free hamster ova at comparable rates to Percoll separation.
Explore the source record for details and available documents.